RDHL RedHill Biopharma ADRs

RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:RDHL.

$7.89  +0.06 (0.77%)
As of 03/08/2021 11:10:09 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Small cap
Health Care
Drug Manufacturers—Specialty &
Israel
Israel
02/11/2013
41,586,922
734,398
$325,625,599
0.00%
SEC Edgar Online
20-F
757468103
US7574681034
B96DLZ7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-5.13
10.16
7.32
-221.02%
-142.81%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy